Advanced Malignant Solid Neoplasm
Conditions
Brief summary
This clinical trial develops effective and appropriate mindfulness-based interventions that help meet the needs of Latino cancer patients and their family caregivers. Mindfulness-based interventions focus on building awareness of thoughts, emotions/feelings, and the sensations. This study may help improve mental well-being and reduce stress and anxiety associated with having cancer or with a family member's cancer diagnosis.
Detailed description
PRIMARY OBJECTIVES: I. Systematically and culturally adapt a mindfulness-based intervention to improve psychological wellbeing in Latino patients with advanced cancer and their family caregivers. II. Evaluate the feasibility of the adapted mindfulness-based intervention and overall study procedures in Latino patient-family caregiver dyads. SECONDARY OBJECTIVE: I. Determine the effects of the adapted mindfulness-based intervention on the secondary outcomes of patient and caregiver psychological distress, quality of life (QOL), and patient cancer symptoms, compared to a waitlist control. OUTLINE: Patients and their partners are randomized to 1 of 32 groups. GROUP I: Patients and their partners participate in mindfulness program together over 60 minutes consisting of meeting with a mindfulness coach to build awareness of thoughts, emotions, feelings, and sensations 1 time per week (QW) for 4 weeks. GROUP II: Patients and their partners participate in mindfulness program separately over 60 minutes consisting of meeting with a mindfulness coach to build awareness of thoughts, emotions, feelings, and sensations 1 time per week (QW) for 4 weeks. GROUP III: Patients and their partners participate in mindfulness program either separately or together, depending on participants' preferences, as in Group I beginning 12 weeks after starting the study and completing the third study visit.
Interventions
Participate in mindfulness program
Ancillary studies
Ancillary studies
Patients and their partners participate in mindfulness program together or separately, depending on their preference, as in Group I beginning 12 weeks after starting the study and completing the third study visit.
Sponsors
Study design
Eligibility
Inclusion criteria
* Diagnosed with a stage III-IV solid tumor * On active treatment * Self-identify as Hispanic/Latino * ECOG (Eastern Cooperative Oncology Group) performance status of =\< 2 * Willing to participate in the study with a family caregiver (e.g., spouse, adult child) with whom they currently reside and who consents to participate
Exclusion criteria
* At least 18 years old * Able to speak English or Spanish * Have access to the internet * Able to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall accrual | Up to 12 weeks | Will calculate means, frequencies, and 90% confidence intervals (CIs), as applicable. |
| Attrition | Up to 12 weeks | Will calculate means, frequencies, and 90% CIs, as applicable. |
| Adherence | Up to 12 weeks | Will calculate means, frequencies, and 90% CIs, as applicable. |
| Acceptability | Up to 12 weeks | Will calculate means, frequencies, and 90% CIs, as applicable. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient and caregiver psychological distress | At 6 and 12 weeks | Will examine means, standard deviations (SDs), and distributions of survey measures for ceiling/floor effects and restrictions in range and examine change over time. |
| Quality of life questionnaire | At 6 and 12 weeks | Will examine means, SDs, and distributions of survey measures for ceiling/floor effects and restrictions in range and examine change over time. |
| Patient cancer symptoms | At 6 and 12 weeks | Will examine means, SDs, and distributions of survey measures for ceiling/floor effects and restrictions in range and examine change over time. |
Countries
United States
Contacts
M.D. Anderson Cancer Center